Navigation Links


Pfenex Reports Second Quarter 2014 Results and Provides Business Update

8/29/2014
SAN DIEGO, Aug. 29, 2014  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014. "With the successful completion of our initial public offer... [Comments]

Breakthrough in light sources for new quantum technology

8/29/2014
Electronic circuits are based on electrons, but one of the most promising technologies for future quantum circuits are photonic circuits, i.e. circuits based on light (photons) instead of electrons. First, it is necessary to be able to create a stream of single photons and control their direc... [Comments]Breakthrough in light sources for new quantum technology

Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research

8/29/2014
Albany, New York (PRWEB) August 29, 2014 The global companion diagnostics market will be valued at $5.6 billion in 2019. It is expected to grow at a CAGR of 18.1% from 2013 to 2019, and was valued at $1.8 billion in 2013, according to a research report published by Transparency Market Research. For more information regarding analysis details and ToC, please visit: http://www.transparenc... [Comments]

Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research

8/29/2014
Albany, New York (PRWEB) August 29, 2014 According to a new market report published by Transparency Market Research “Global Orthobiologics Market” the global orthobiologics market was valued at USD 3,754.6 million in 2012 and is estimated to reach a market worth USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 to 2019. Nearly half of the population aged 50 years and above is afflict... [Comments]

Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald

8/29/2014
Pittsburgh, PA (PRWEB) August 29, 2014 Pittcon is pleased to announce that the 2015 Program Chairman, Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have organized a session on nanotechnology for presentation at JASIS on September 5, 2014. JASIS , Asia’s largest analytical and scientific instruments show, will be held September 3-5, 2014, in Makuhari Messe, Japan. Th... [Comments]

iCo Therapeutics Announces Second Quarter 2014 Financial Results

8/29/2014
VANCOUVER , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). Second Quarter 2014 Highlights Announced top-line results r... [Comments]

Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis

8/29/2014
Burnt Hills, NY (PRWEB) August 29, 2014 Local veterinarian, Dr. Keith Clement, and his team at Burnt Hills Veterinary Hospital are seeking candidates to participate in an investigational study of donor stem cells for dogs with osteoarthritis. The ultimate goal of this study is to determine if a single injection of donor stem cells into one or two arthritically affected joints can help redu... [Comments]

Livermore Team Awarded for Hydrogen Production Research

8/29/2014
Livermore, California (PRWEB) August 29, 2014 Three Lawrence Livermore researchers have received the Department of Energy's 2014 Hydrogen Production R&D Award for their research in producing hydrogen photoelectrochemically -- by splitting water using sunlight. Shared with collaborators from the National Renewable Energy Laboratory (NREL) and the University of Nevada, Las Vegas... [Comments]

The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies

8/29/2014
Boston, MA (PRWEB) August 29, 2014 Due to a misstatement posted by the Family Resource Council (FRC) last week, the Adult Stem Cell Technology Center, LLC ( ASCTC ) was reported as an entity accepting donations to support stem cell therapy research that might benefit ALS patients. Because of ASCTC's exclusive focus on developing adult stem cells for new stem cell technologies and the... [Comments]

The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End

8/29/2014
Boston, MA (PRWEB) August 29, 2014 A major challenge before new biotechnology start-up companies, especially ones in the biotech start-up dense realm of Boston-Cambridge, is gaining visibility that can lead to important strategic alliances and able investors. James Sherley, the Director of Boston’s Adult Stem Cell Technology Center, LLC (ASCTC), has made increasing the local and national vi... [Comments]

[next]
(Date:8/28/2014)... than traditional cigarettes, but still release toxins into ... USC. , Scientists studying secondhand smoke from e-cigarettes ... harmful particles, with close-to-zero exposure to organic carcinogens. ... in second-hand e-cigarette smoke were found to be ... levels of polycyclic aromatic hydrocarbons cancer-causing organic ...
(Date:8/28/2014)... groups and clinicians is critical to the development ... of Georgia research. , A qualitative study of ... that role models for successful breastfeeding help positively ... "Mothers who received that support are more likely ... Alex Anderson, an associate professor in the College ...
(Date:8/28/2014)... complex systems. Their infrastructure equipment requires ancillary sub-systems ... to supply fuel, and ICT systems for control ... is interconnected with a wider network and they ... scientists has studied various aspects of inter-network dependencies, ... in EPJ B by Gaihua Fu from Newcastle ...
Breaking Biology News(10 mins):Second-hand e-cig smoke compared to regular cigarette smoke 2Breastfeeding study shows need for effective peer counseling programs 2Inter-dependent networks stress test 2
... by Dr. Ann F. Jacobson, associate professor in Kent ... may initially choose to postpone but ultimately undergo total ... patient education before and after the procedure. ... pre-and post operative experiences with total knee replacement surgery, ...
... release is available in Spanish . , A ... (USA) and Nakai (China), among others, have deciphered for the first ... to the cover of the last issue of the prestigious journal ... to the group of Molecular Genetics of the Department of ...
... fund four faculty research projects for spring 2008. ... a number of excellent proposals submitted in response ... for the program is administered by the OSU ... by royalties from OSU-licensed technologies. These funded projects ...
Cached Biology News:Research examines factors in delaying or declining total knee replacement surgery 2Scientists decipher fruit tree genome for the first time 2Scientists decipher fruit tree genome for the first time 3OSU technologies funded for development 2OSU technologies funded for development 3
... Maxi MB (for aqueous, other low volatility ... systems respond to specific applications of molecular ... concentration of heat-labile samples. The RC systems ... cold traps and a wide selection of ...
... Acid Resistant SpeedVac Model SPD131DDA , Our ... SPD131DDA is designed to handle the rigors and ... slim design, digital display, dual independent timers, an ... chamber and vapor pathway. , , Adjustable ...
...
For absolute protein quantification. 4 peptides in 5 vials x 2 nmol per peptide...
Biology Products:
(Date:8/29/2014)... Antonio, TX (PRWEB) August 29, 2014 ... and ISO 13485:2003 certified, GAMP® 5 compliant imaging ... awarded an international Phase II clinical trial to ... lymphoma. , Throughout this trial, Intrinsic Imaging will ... not limited to, protocol and charter development, site ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
(Date:8/28/2014)... August 28, 2014 The ability for ... culture that will allow individuals to perform at the ... important for employers looking to compete in this post–recession ... embracing this trend, as the sector increasingly focuses on ... company, which will have real results on the organization's ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... China, FORT LAUDERDALE, Fla., Sept. 5 ... pioneer in laser,optical breast cancer imaging systems, has ... Tianjin Medical University,s Cancer Institute and,Hospital, the largest ... http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ) Research at the Cancer ...
... EDMONTON, Sept. 5 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: ... of three-year survival results,from a randomized Phase II ... lung cancer (NSCLC). The results suggest that Stimuvax,combined ... benefits to,patients with unresectable stage IIIB NSCLC who ...
... FRANCISCO, Calif., Sept. 5 Hyperion,Therapeutics, a biopharmaceutical ... and hepatology therapies for the,treatment of Urea Cycle ... $40 million Series B financing. Leading the round ... Partners and,NEA, all of Menlo Park, CA. WRF ...
Cached Biology Technology:Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 2Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 2Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 4Hyperion Therapeutics Secures $40 Million In Series B Round 2